disseminated

E1210 (APX001A) is broad-spectrum and orally active antifungal

Gabexate mesylate (FOY) is a serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Sivelestat sodium tetrahydrate (ONO5046 sodium tetrahydrate) is a competitive inhibitor of human neutrophil elastase, with an IC50 of 44 nM and a Ki of 200 nM. Sivelestat (EI546) sodium tetrahydrate has the potential for the study of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.

iKIX1 is an Pdr1-dependent gene activation. It re-sensitizes drug-resistant C. glabrata to azole antifungals in vitro and in animal models for disseminated and urinary tract C. glabrata infection.

Apoptotic agent-6 (NSC-647889) is an apoptosis-inducing compound. It effectively triggers apoptosis in the peripheral cells of multicellular spheroids (MCS) and is applicable in the study of solid tumors, particularly disseminated solid tumors.

RGH-1875 (GYKI 39521) hydriodide is the hydriodide salt form of RGH-1875, which is an orally active antithrombotic agent. It prevents the reduction of fibrinogen levels and platelet counts induced by endotoxins, reduces levels of fibrin degradation products, and inhibits the enhancement of endotoxin-induced fibrinolytic activity in a rabbit model of endotoxin-induced disseminated intravascular coagulation. RGH-1875 is applicable for research on thrombotic disorders.

RGH-1962 is an orally active antithrombotic agent. It prevents the endotoxin-induced reduction in fibrinogen levels and platelet count, decreases fibrin degradation product levels, and inhibits the enhancement of fibrinolytic activity in an endotoxin-induced disseminated intravascular coagulation model in rabbits. RGH-1962 is applicable for research in thrombotic diseases.

PKSI-527 is a non-covalent, highly selective small molecule inhibitor of plasma kallikrein with an inhibition constant (Ki) of 0.81 µM for plasma kallikrein. PKSI-527 modulates the kallikrein-kinin system by inhibiting bradykinin generation, significantly reduces arthritis severity in a collagen-induced arthritis mouse model, and improves indicators of disseminated intravascular coagulation and organ damage in endotoxin-induced rat models.

Anpocogin, a variant of the Ancyclostoma canium nematode anticoagulant protein c2 with an added C-terminal P85, is synthesized in Pichia pastoris and functions as an anticoagulant agent [1].Recombinant nematode anticoagulant protein c2 (rNAPc2) is a potent inhibitor of serine protease factor VIIa and its cell-associated cofactor tissue factor FVIIa/TF, a key physiological initiator of blood coagulation, with potential efficacy in the treatment of disseminated intravascular coagulopathy and venous and arterial thrombosis.